Morning Movers 7/31: ANDS, NVTL, TOMO, RODM, DISK Higher; SYNA, ARIA, HTCH, PIR, AWRE, GPRO, PKI Lower Jul 31, 2009 09:54AM

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) 44.4% HIGHER; announced finalization of the protocol for the Company's Phase II trial of ANA598 in combination with pegylated interferon-alpha and ribavirin in hepatitis C patients. Allowance of the protocol has been received from the US FDA, and patient dosing is expected to commence within the next several weeks. Also reported a Q2 loss of $0.21, 7 cents better than the analyst estimate of ($0.28).

Synaptics Inc. (Nasdaq: SYNA) 26.9% LOWER; reported Q4 EPS of $0.36, below the consensus of $0.44. Revenues came in at $115.3 million, versus the consensus of $112.1 million. The company sees 2010 revenues of $495-$525 million, versus the consensus of $522.5 million. Also announced that its Chairman and CEO will be retiring. The stock was downgraded to Hold at Jefferies.

Novatel Wireless (Nasdaq: NVTL) 23.2 ...